Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Excessive yawning and SSRI therapy.

Mark D. Beale, Timothy M. Murphree

    The International Journal of Neuropsychopharmacology
    |May 10, 2001
    PubMed
    Summary

    Selective serotonin reuptake inhibitors (SSRIs) can cause subtle side effects like excessive yawning. This study presents two cases linking SSRI antidepressant therapy to this uncommon adverse event.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    PDE4A knockdown rescues alcohol-induced cognitive impairment and synaptic dysfunction via the cAMP/PKA/CREB pathway.

    The international journal of neuropsychopharmacology·2026
    Same journal

    Ketamine effects on EEG and their links to therapy differ across treatment-resistant major depression, post-traumatic stress disorder, and obsessive-compulsive disorder.

    The international journal of neuropsychopharmacology·2026
    Same journal

    Genetic overlap between treatment-resistant schizophrenia and smoking initiation.

    The international journal of neuropsychopharmacology·2026
    Same journal

    External validation as the critical step for predictive biomarkers.

    The international journal of neuropsychopharmacology·2026
    Same journal

    Viloxazine occupies the 5-HT2C receptor in the macaca fascicularis brain in vivo: A [11C]CIMBI-36 positron emission tomography study.

    The international journal of neuropsychopharmacology·2026
    Same journal

    Divergent effects of interleukin-6 and ghrelin on remission and relapse in depression treatment.

    The international journal of neuropsychopharmacology·2026

    Area of Science:

    • Psychiatry
    • Pharmacology

    Background:

    • Long-term use of selective serotonin reuptake inhibitors (SSRIs) may reveal subtle side effects.
    • Yawning is a recognized, though infrequently documented, side effect of antidepressant therapy.

    Purpose of the Study:

    • To report two cases of excessive daytime yawning associated with SSRI treatment.
    • To highlight a subtle side effect of SSRI medications.

    Main Methods:

    • Case study presentation.
    • Review of patient history and medication logs.

    Main Results:

    • Two patients experienced excessive daytime yawning.
    • Yawning episodes were temporally associated with the initiation or continuation of SSRI therapy.

    Conclusions:

    • Excessive daytime yawning may be an underreported side effect of SSRIs.
    • Clinicians should consider SSRI-induced yawning in patients presenting with this symptom.

    Related Experiment Videos